Transhuman Capital - aVenture Asset Manager Research
Location
Ann Arbor, MI, US
Founded
2014
Transhuman Capital is a venture capital firm focused on investing in transformative medical technologies, including therapeutics and medical devices. The firm targets investments that have the potential to fundamentally improve the human condition, with a vision of creating a society where everyone can live a long, healthy, and meaningful life. They typically invest across various stages, including Seed, Series A, Series B, and Series C rounds.
Notable portfolio companies include Kriya Therapeutics, which has raised a total of $450.5 million. Transhuman Capital is driven by a mission to solve humanity's big problems through hard science. The firm's key partners and decision-makers bring extensive experience in the healthcare and technology sectors, providing valuable insights and strategic guidance to their portfolio companies. Additionally, they offer unique value-add services to support the growth and success of their investments.
Transhuman Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
